Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL672619 | 1.00 | THRB (0.38) | THRBTET2 | |
| Acetic Acid SCHEMBL29256055 | 0.88 | THRB (0.43) | THRB | |
| Acetic Acid SCHEMBL29256049 | 0.86 | THRB (0.39) | THRB | |
| Methacrylic Acid SCHEMBL28737039 | 0.85 | THRB (0.38) | THRB | |
| Methacrylic Acid SCHEMBL31316646 | 0.84 | THRB (0.50) | THRBTET2 | |
| Perflubutane SCHEMBL5248074 | 0.82 | THRB (0.46) | THRBTET2 | |
| SCHEMBL3145629 | 0.82 | LMNA (0.35) | THRB | |
| SCHEMBL2378730 | 0.82 | LMNA (0.35) | THRB | |
| SCHEMBL7886337 | 0.82 | LMNA (0.35) | THRB | |
| SCHEMBL11588700 | 0.82 | LMNA (0.35) | THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110257016-A1 | Gel Formulations that are Stable for Storage, Comprising at Least Two Substantially Unmixed Hydrogels | BASF SE (DE) | 2011-10-20 | — | — | US | disclosed |
| US-7566763-B2 | Stable dispersion concentrates | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2009-07-28 | — | — | US | disclosed |
| US-20080026022-A1 | Process for the preparation of stable polymer concentrates | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH | 2008-01-31 | — | — | US | disclosed |
| US-7300914-B2 | Process for the preparation of stable polymer concentrates | CLARIANT PRODUKTE (DEUTSCHLAND) GMBH (DE) | 2007-11-27 | — | — | US | disclosed |
| US-20040259759-A1 | Process for the preparation of stable polymer concentrates | CLARIANT GMBH | 2004-12-23 | — | — | US | disclosed |
| US-20030232028-A1 | Stable dispersion concentrates | CLARIANT GMBH | 2003-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110257016-A1 | Gel Formulations that are Stable for Storage, Comprising at Least Two Substantially Unmixed Hydrogels | HSP90AA1, HSP90B1, HSPA1B | THRB 4426/4885TET2 4429/4885 |
| US-20080026022-A1 | Process for the preparation of stable polymer concentrates | TPMT, DPYD, APRT | THRB 4818/4885TET2 92/4885 |
| US-20030232028-A1 | Stable dispersion concentrates | FUS, CFD, C9 | THRB 4469/4885TET2 2003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.